- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02933307
Continuous Monitoring on the General Ward
Continuous Monitoring of Vital Signs in Hospitalized Patients
Rationale: Monitoring patients' vital signs is done to detect clinical deterioration. For this, the MEWS, a scoring list comprising seven vital signs measured by nursing staff, is used. Although the MEWS provides relevant data on patients' health status, the interval measurements may not capture early deterioration of vital signs, especially during the night. As a result, unsafe situations may occur such as periods of low oxygen saturation and cardiac arrhythmias, which are known to complicate postoperative course. Besides, this way of measuring vital signs may be stressful for patients and disturbs patients' sleep. New technology such as ViSi Mobile and HealthPatch allows for remote continuous monitoring of vital signs using wearable devices transmitting relevant data to nurses and clinicians. With this, the investigators think that clinical deterioration may be detected in an early phase and reduce nurse work load and patient distress.
Objective: to investigate the feasibility of wearable devices on the general ward.
Study design: feasibility study.
Study population: adult patients hospitalized on the internal medicine ward and adult postoperative patients on the surgical ward.
Intervention: patients in the intervention groups will be randomized in one of the two groups. Patients in the group 1 will wear ViSi Mobile; patients in group 2 will wear the HealthPatch. Wearable devices will be worn for at least three days. Regular MEWS measurements take place at usual time points.
Main study parameters/endpoints: Evaluation with patient and care givers (primary outcome measure), MEWS calculations, time between alarm (continuous data) and next regular MEWS measurement (nurse), intervention by nurse after alarm, admission to ICU, complications, side effects of devices, STAI scores, and PCS scores will be documented.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients will wear one device for at least three days. Devices can be uncomfortable by being heavy or the patches can start itching. More measurements by nurses can take place when indicated, for example after alarms. The participating patients will fill out the STAI on daily basis and the PCS on the last day of hospitalization. Both questionnaires will take a few minutes to complete. Patients could benefit from early detection of clinical deterioration and early corrective interventions or ICU admissions.
Przegląd badań
Status
Interwencja / Leczenie
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Patient is 18 years or older on the day the informed consent will be signed.
- Patient is hospitalized on the surgical or internal medicine ward.
- MEWS measurements are required at least three times a day.
- Patient is able to speak, read and understand the local language of the investigational site, is familiar with the procedures of the study, and agrees to participate in the study program by giving oral and written informed consent prior to screening evaluations.
Exclusion Criteria:
- Frequency of MEWS measurements is less than three times a day.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Zapobieganie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Brak interwencji: Control group
Patients with regular measurements by nurses only (Modified Early Warning Score (MEWS))
|
|
Eksperymentalny: HealthPatch (Intervention)
Patients with HealthPatch and regular MEWS measurements
|
The HealthPatch (Vital Connect) is a wireless patch and continuously measures single-lead ECG, heart rate, respiratory rate, stress, skin temperature, body posture and steps
|
Eksperymentalny: ViSi Mobile (Intervention)
Patients with ViSi Mobile and regular MEWS measurements
|
ViSi Mobile (Sotera Wireless) is wireless device that is able to continuously measure all important vital parameters: ECG, heart rate, oxygen saturation, blood pressure, respiratory rate and skin temperature.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Expectations & experiences of patients
Ramy czasowe: 2-3 days after informed consent
|
Interviews of 15-20 minutes with patients after 2-3 days wearing a device or control group
|
2-3 days after informed consent
|
Expectations & experiences of care givers
Ramy czasowe: 1 year
|
Interviews with nurses of 15-20 minutes at the end of the study.
Estimated amount of 6 nurses
|
1 year
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
MEWS scores based on continuous data and data measured by nurses
Ramy czasowe: 3 times a day, up to three days.
|
3 times a day, up to three days.
|
|
Amount of alarms by HealthPatch or ViSi Mobile
Ramy czasowe: during 2-3 days when the patient wears a device
|
during 2-3 days when the patient wears a device
|
|
Time between alarm (continuous data) and next regular MEWS measurement (nurse)
Ramy czasowe: during 2-3 days when the patient wears a device
|
during 2-3 days when the patient wears a device
|
|
Amount of extra MEWS measurements by nurses due to alarms
Ramy czasowe: during 2-3 days when the patient wears a device
|
during 2-3 days when the patient wears a device
|
|
Admission to ICU (yes/no)
Ramy czasowe: during 2-3 days when the patient participates in this study
|
during 2-3 days when the patient participates in this study
|
|
Duration of ICU hospitalization in days
Ramy czasowe: during 2-3 days when the patient participates in this study
|
during 2-3 days when the patient participates in this study
|
|
Complications caused by disease or surgical procedure
Ramy czasowe: during 2-3 days when the patient participates in this study
|
during 2-3 days when the patient participates in this study
|
|
Adverse events caused by devices
Ramy czasowe: during 2-3 days when the patient wears a device
|
E.g. Itch or redness
|
during 2-3 days when the patient wears a device
|
Technical failures of devices (artifacts: a period longer than 1 minute the device does not measure vital parameters)
Ramy czasowe: during 2-3 days when the patient wears a device
|
during 2-3 days when the patient wears a device
|
|
Outcomes of the State Trait Anxiety Inventory (STAI)
Ramy czasowe: Once a day during the 2-3 days the patient participantes in this study
|
Once a day during the 2-3 days the patient participantes in this study
|
|
Outcomes of the Pain Catastrophizing Scale (PCS)
Ramy czasowe: On day 2 or 3 when patients participates in the study
|
On day 2 or 3 when patients participates in the study
|
|
System usability Scale
Ramy czasowe: 1 year
|
1 year
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Gender
Ramy czasowe: On day 1 when patients participates in the study
|
Extraction from EHR
|
On day 1 when patients participates in the study
|
Age
Ramy czasowe: On day 1 when patients participates in the study
|
Extraction from EHR
|
On day 1 when patients participates in the study
|
Diagnosis
Ramy czasowe: On day 1 when patients participates in the study
|
Extraction from EHR
|
On day 1 when patients participates in the study
|
Performed surgical procedure
Ramy czasowe: On day 1 when patients participates in the study
|
Extraction from EHR
|
On day 1 when patients participates in the study
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Harry van Goor, MD, PhD, FRCS, Radboud University Medical Center
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
- Choroby Układu Pokarmowego
- Nowotwory według typu histologicznego
- Nowotwory
- Nowotwory według lokalizacji
- Rak gruczołowy
- Rak
- Nowotwory gruczołowe i nabłonkowe
- Choroby układu hormonalnego
- Nowotwory przewodu pokarmowego
- Nowotwory Układu Pokarmowego
- Choroby przewodu pokarmowego
- Nowotwory gruczołów dokrewnych
- Choroby okrężnicy
- Choroby jelit
- Nowotwory jelit
- Choroby odbytu
- Choroby trzustki
- Nowotwory, przewodowe, zrazikowe i rdzeniaste
- Nowotwory trzustki
- Rak przewodowy
- Nowotwory jelita grubego
- Rak przewodu trzustkowego
Inne numery identyfikacyjne badania
- HEEL-2015-03
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Posocznica
-
Drugs for Neglected DiseasesUniversiteit Antwerpen; PENTA Foundation; St George's, University of LondonZakończonySEPSIS noworodkówBangladesz, Uganda, Tajlandia, Afryka Południowa, Włochy, Grecja, Indie, Brazylia, Chiny, Kenia, Wietnam
-
Assiut UniversityNieznany
-
Assiut UniversityNieznany
-
Ahmed Mahmoud Ali Ali YoussefZakończony
-
Assiut UniversityNieznany
-
London School of Hygiene and Tropical MedicineZakończonySEPSIS noworodkówBurkina Faso, Gambia
-
Stephanie BjerrumRigshospitalet, Denmark; University of Copenhagen; University of Ghana; Korle-Bu...Zakończony
-
Drugs for Neglected DiseasesUniversity of Oxford; KEMRI-Wellcome Trust Collaborative Research ProgramZakończonySEPSIS noworodkówKenia
-
Gehad AbdelnaserAssiut UniversityNieznany
-
Franciscus GasthuisErasmus Medical CenterZakończonyZakażenie noworodków | SEPSIS noworodkówHolandia